Temporal trajectory of quality of life and its predictors in recipients of hematopoietic stem cell transplantation

被引:0
作者
Ryul Kim
Kyung-Lak Son
Kwang-Min Lee
Younak Choi
Junshik Hong
Dong-Yeop Shin
Youngil Koh
Bong-Jin Hahm
Inho Kim
机构
[1] Seoul National University Hospital,Department of Internal Medicine
[2] Seoul National University Hospital,Department of Neuropsychiatry
[3] Seoul National University Hospital,Public Health Medical Service
[4] Gyeonggi Provincial Medical Center Uijeongbu Hospital,Department of Psychiatry
[5] Seoul National University College of Medicine,Cancer Research Institute
来源
Annals of Hematology | 2018年 / 97卷
关键词
Stem cell transplantation; Quality of life; Supportive care; Distress;
D O I
暂无
中图分类号
学科分类号
摘要
This prospective longitudinal study evaluated the temporal trajectory of health-related quality of life (HRQOL) and its associated factors in patients who received hematopoietic stem cell transplantation (SCT) 6 months after transplantation. Eighty-nine adult patients who were admitted to Seoul National University Hospital for SCT were consecutively included in the study. The participants completed three standardized questionnaires: Insomnia Severity Index, Hospital Anxiety and Depression Scale, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire. The participants completed the study questionnaires at three time points: before SCT (T1), immediately after SCT (T1), and 6 months after SCT (T3). Immediately after SCT, HRQOL decreased significantly (p < 0.001), followed by recovery over 6 months. The conditioning regimen for SCT showed no correlation with HRQOL at T2 (p = 0.283) or T3 (p = 0.799), with no significant difference in HRQOL between allogeneic and autologous SCT recipients at T2 (p = 0.829) or T3 (p = 0.824). Depression (p = 0.042), pain (p = 0.023), and appetite loss (p = 0.004) negatively influenced HRQOL at T1, whereas only pain (p = 0.048) remained an important factor at T2. Six months after SCT, the two most frequent symptoms, fatigue and financial problems, became major factors (p = 0.004 and p = 0.005, respectively). Depression began to play an important role in HRQOL again at T3 (p = 0.040). These findings demonstrate that SCT recipients need both psychological and medical support to achieve a better HRQOL after SCT.
引用
收藏
页码:1407 / 1415
页数:8
相关论文
共 235 条
[1]  
Fuji S(2016)Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 52 657-662
[2]  
Loffler J(2000)Patient reports of complications of bone marrow transplantation Support Care Cancer 8 33-39
[3]  
Savani BN(2002)Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation Bone Marrow Transplant 30 619-626
[4]  
Einsele H(1995)Quality of life in adult cancer patients treated with bone marrow transplantation--a review of the literature Eur J Cancer (Oxford, England : 1990) 31a 163-173
[5]  
Kapp M(1998)The psychosocial impact of bone marrow transplantation: a review of the literature Bone Marrow Transplant 22 409-422
[6]  
Bellm LA(1998)Quality of life following bone marrow transplantation Curr Opin Oncol 10 108-111
[7]  
Epstein JB(2012)New patient-centered care standards from the commission on cancer: opportunities and challenges J Support Oncol 10 107-111
[8]  
Rose-Ped A(2006)Distress, anxiety, and depression in cancer patients undergoing chemotherapy World J Surg Oncol 4 68-68
[9]  
Martin P(2004)Prevalence of depression in patients with cancer JNCI Monographs 2004 57-71
[10]  
Fuchs HJ(2014)Psychosocial factors predicting survival after allogeneic stem cell transplant Support Care Cancer 22 2547-2555